Skip to main content
Advertisement
Advertisement

SPTX

SPTX logo

Seaport Therapeutics, Inc. Common Stock

17.15
USD
Sponsored
-1.00
-5.51%
Oct 12, 15:59 UTC -4
Closed
exchange

After-Market

17.15

0.00
0.00%

SPTX Earnings Reports

Positive Surprise Ratio

SPTX beat 0 of 2 last estimates.

0%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Seaport Therapeutics, Inc. Common Stock earnings per share and revenue

On Aug 03, 2026, SPTX reported earnings of -0.73 USD per share (EPS) for Q2 26, missing the estimate of -0.62 USD, resulting in a -16.69% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.93% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
NanoViricides Inc.
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$0.10
Actual
-$0.10
Surprise
+1.96%
FAQ
For Q2 2026, Seaport Therapeutics, Inc. Common Stock reported EPS of -$0.73, missing estimates by -16.69%, and revenue of $0.00, 0% as expectations.
The stock price moved up 0.93%, changed from $20.46 before the earnings release to $20.65 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Seaport Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement